Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028

DexCom, Inc. (Nasdaq: DXCM) (“Dexcom”) announced today the pricing of its offering of $1.1 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2028 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers…

Read MoreDexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028

2 Day Training Course on Advanced Regulatory Affairs for Medical Devices: October 9-10, 2023 – ResearchAndMarkets.com

The regulatory environment for medical devices is in a transitional period. With the increased focus on patient safety, the MDR has introduced many changes to the requirements and processes involved. Designed for professionals with a working knowledge of medical device…

Read More2 Day Training Course on Advanced Regulatory Affairs for Medical Devices: October 9-10, 2023 – ResearchAndMarkets.com

Thubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study With Novel Optimum TAV™ at EuroPCR 2023

Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis will be presented at the upcoming EuroPCR 2023 Conference. EuroPCR…

Read MoreThubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study With Novel Optimum TAV™ at EuroPCR 2023

Nexa3D Delivers Breakthrough Economics for Additive Production with the Launch of XiP Pro Industrial 3D Printer

The ultrafast polymer 3D printing leader, announced today at Rapid + TCT 2023 the immediate availability of its XiP Pro ultrafast industrial 3D printer, providing the highest daily production throughput and lowest total cost of ownership in its class. Featuring print speeds…

Read MoreNexa3D Delivers Breakthrough Economics for Additive Production with the Launch of XiP Pro Industrial 3D Printer

Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function

Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced that data from its BIOADAPTOR RCT randomized controlled trial (RCT), an international, multicenter, single-blind study enrolling 445 patients will be presented at the EuroPCR conference in Paris. The data compare…

Read MoreElixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function
RestorixHealth

Rootine Recognized in Fast Company’s 2023 World Changing Ideas Awards Honorable Mention in Wellness Category

The winners of Fast Company’s 2023 World Changing Ideas Awards were announced today, honoring sustainable designs, innovative products, bold social initiatives, and other creative projects that are changing the way we work, live, and interact with the world. Rootine earned an…

Read MoreRootine Recognized in Fast Company’s 2023 World Changing Ideas Awards Honorable Mention in Wellness Category